Veeva Funding: How Much Did They Raise & Key Investors

How Much Did Veeva Raise?
Funding & Key Investors

Veeva has solidified its position as a cornerstone of the life sciences technology sector, demonstrating significant financial maturity through a series of strategic capital raises. With a cumulative total funding amount reaching $258M, the organization has successfully navigated the transition from a venture-backed startup to a dominant enterprise-level provider. The most recent strategic investment of $35M underscores the market confidence in the company's integrated cloud platform and its capacity to drive digital transformation across the pharmaceutical and biotechnology landscapes.

This capital trajectory reflects a deliberate growth strategy, moving from initial Series A and B rounds to substantial public market offerings. By securing this level of financing, Veeva has effectively scaled its operations to meet the complex regulatory and research demands of global healthcare organizations, ensuring its infrastructure remains the industry standard for product development and commercialization.

What is Veeva?

Veeva

Software

Customer Engagement Platforms

Veeva operates as a premier provider of cloud-based software, data, artificial intelligence, and business consulting solutions tailored specifically for the life sciences industry. The company's integrated industry cloud serves as a critical backbone for pharmaceutical, biotechnology, and medical device firms, facilitating streamlined research, development, and regulatory management. By enabling more efficient engagement with healthcare professionals and accelerating the delivery of therapies to patients, Veeva has established a unique market position that bridges the gap between complex scientific processes and modern enterprise software efficiency. Its platform is designed to handle the rigorous compliance and data integrity requirements inherent in global health sectors, making it an indispensable partner for organizations navigating the modern clinical and commercial environment.

How much funding has Veeva raised?

Veeva has raised a total of $258M across 4 funding rounds:

2007

Series A

$3M

2008

Series B

$4M

2013

Stock Offering

$216M

2014

Stock Offering

$35M

Series A (2007): $3M with participation from Undisclosed

Series B (2008): $4M led by Emergence Capital Partners

Stock Issuance/Offering (2013): $216M supported by Undisclosed

Stock Issuance/Offering (2014): $35M featuring Undisclosed

Key Investors in Veeva

Emergence Capital Partners

Emergence is the leading venture capital firm focused on early-stage enterprise companies. Its mission is to be the most valuable partner to the most important companies that are changing the way the world works.

Undisclosed Investors

What's next for Veeva?

Looking ahead, Veeva is positioned to leverage its robust capital base to further integrate artificial intelligence and advanced data analytics into its core product suite. As the life sciences industry faces increasing pressure to shorten drug development cycles and improve patient outcomes, the company's strategic focus will likely center on expanding its footprint in emerging biotech markets and enhancing its regulatory compliance modules. The recent influx of capital provides the necessary runway to pursue aggressive R&D initiatives and potential strategic acquisitions that could further consolidate its dominance in the life sciences cloud ecosystem. By maintaining its commitment to industry-specific innovation, Veeva is well-equipped to address the evolving challenges of global healthcare, ensuring that its software remains the primary engine for scientific and commercial progress.

See full Veeva company page

See More Financial Insights